Fluoxetine Janus dendrimer shows potent anticancer activity against MCF-7 cells
Fluoxetine Janus dendrimers demonstrated significant cytotoxicity against MCF-7 cancer cells, indicating potential for new treatment strategies.
Asset / Drug
Drug and asset intelligence for fluoxetine with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Dendrimer-based therapy
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.